| P2093 | author name string | Michael Potegal | |
| | Gabrielle A Carlson | |
| | Zinoviy Gutkovich | |
| | David Margulies | |
| | Joann Basile | |
| P2860 | cites work | Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder | Q22242745 |
| | Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder | Q22242775 |
| | A rating scale for drug-induced akathisia | Q28258433 |
| | The behavioral organization, temporal characteristics, and diagnostic concomitants of rage outbursts in child psychiatric inpatients | Q33346910 |
| | Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation | Q33411020 |
| | Rages--what are they and who has them? | Q33799273 |
| | Risperidone in children with autism and serious behavioral problems | Q33960551 |
| | Practice parameter for the prevention and management of aggressive behavior in child and adolescent psychiatric institutions, with special reference to seclusion and restraint | Q34113193 |
| | Clinical course of children and adolescents with bipolar spectrum disorders | Q34814593 |
| | Treating the childhood bipolar controversy: a tale of two children | Q34914888 |
| | Defining clinical phenotypes of juvenile mania | Q35075420 |
| | A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents | Q36698557 |
| | Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. | Q36741979 |
| | A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed | Q36932671 |
| | Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation | Q43577322 |
| | Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence | Q44086833 |
| | The utility of a DSM-III-R-based checklist in screening child psychiatric patients | Q44933689 |
| | How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates. | Q50956029 |
| | Heterogeneity of irritability in attention-deficit/hyperactivity disorder subjects with and without mood disorders. | Q50960243 |
| | P.r.n. medications in child psychiatric patients: a pilot placebo-controlled study | Q51702505 |
| | Further evidence of reliability and validity of the Child Symptom Inventory-4: parent checklist in clinically referred boys. | Q51952602 |
| | Best estimate of lifetime psychiatric diagnosis: a methodological study. | Q52098061 |
| | A rating scale for extrapyramidal side effects | Q53780342 |
| | Test-retest reliability of team consensus best-estimate diagnoses of axis I and II disorders in a family study | Q72012691 |
| | Use of droperidol in hospitalized children | Q74215398 |
| P433 | issue | 2 | |
| P921 | main subject | risperidone | Q412443 |
| | hospitalization | Q3140971 |
| | bipolar disorder | Q131755 |
| P304 | page(s) | 205-212 | |
| P577 | publication date | 2010-03-01 | |
| P1433 | published in | Bipolar Disorders | Q15716681 |
| P1476 | title | Liquid risperidone in the treatment of rages in psychiatrically hospitalized children with possible bipolar disorder | |
| P478 | volume | 12 | |